Progression of eIF4E gene amplification and overexpression in benign and malignant tumors of the head and neck

Cancer

Volumn 88, Issue 12, 2000, Pages 2803-2810

  Haydon, M Scott ^a   Googe, J David ^a   Sorrells, Donald S ^a   Ghali, G E ^a   Li, Benjamin D L ^a  

^a LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

Author keywords

eIF4E gene amplification; eIF4E gene overexpression; Head and neck carcinomas; Pleomorphic adenomas

Indexed keywords

DNA; INITIATION FACTOR 4E; MESSENGER RNA; ONCOPROTEIN;

5' UNTRANSLATED REGION; ARTICLE; CANCER GROWTH; CONTROLLED STUDY; GENE AMPLIFICATION; GENE OVEREXPRESSION; HEAD AND NECK CARCINOMA; HEAD AND NECK TUMOR; HUMAN; HUMAN TISSUE; MALIGNANT TRANSFORMATION; PLEOMORPHIC ADENOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; WESTERN BLOTTING;

ADENOMA, PLEOMORPHIC; BLOTTING, WESTERN; CELL TRANSFORMATION, NEOPLASTIC; DNA, NEOPLASM; EUKARYOTIC INITIATION FACTOR-4E; GENE AMPLIFICATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAD AND NECK NEOPLASMS; HUMANS; PEPTIDE INITIATION FACTORS; POLYMERASE CHAIN REACTION; PRECANCEROUS CONDITIONS;

EID: 0034660176     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0142(20000615)88:12<2803::AID-CNCR20>3.0.CO;2-5     Document Type: Article

References (21)

1. Rhoads R. Regulation of eukaryotic protein synthesis by initiation factors. J Bio Chem 1993;268:3017-20.
2. Sonenberg N. mRNA 5′ cap-binding protein eIF-4E and control of cell growth. In: Hershey J, Mathews M, Sonenberg N, editors. Translational control. New York: Cold Spring Harbor Laboratory Press, 1996:245-70.
3. DeBenedetti A, Rhoads R. Overexpression of eukaryotic protein synthesis initiation factoreIF4E in HeLa cells results in aberrant growth and morphology. Proc Natl Acad Sci USA 1990;87:8212-6.
4. Kevil C, Carter P, Hu B, DeBenedetti A. Translational enhancement of FGF-2 by eIF-4 factors, and alternate utilization of CUG and AUG codons for translation initiation. Oncogene 1995;11:2339-48
5. Rosenwald I, Lazaris-Karatzas A, Sonenenberg N, Schmidt E. Elevated levels of cyclin D1 in response to increased expression of eukaryotic initiation factoreIF4E. Mol Cell Biol 1993; 13:7358-63.
6. Nathan CO, Liu L, Li BDL, Abreo FW, Nandy I, DeBenedetti A. Detection of proto-oncogene eIF4E in surgical margins may predict recurrence in head and neck cancer. Oncogene 1997;15:579-84.
7. Kerekatte V, Smiley K, Hu B, Smith A, Gelder F, DeDenedetti A. The proto-oncogene/translation factor eIF4E: a survey of its expression in breast carcinomas. Int J Cancer 1995;64:27-31.
8. Li BDL, Liu L, Dawson M, DeBenedetti A. Overexpression of eukaryotic initiation factoreIF4E (eIF4E) in breast carcinoma. Cancer 1997;79:2385-90.
9. Li, BDL, McDonald JC, Nassar R, DeBenedetti A. Clinical outcome in stage I to III breast carcinoma and eIF4E overexpression. Ann Surg 1998;227:756-63.
10. Sorrells DL, Ghali G, Li BDL, Meschonat C, DeFatta RJ, Black D, et al. Competitive PCR to detect eIF4E gene amplification in head and neck cancer. Head Neck 1999;21:60-5.
11. Sorrells DL, Black DR, Meschonat C, Rhoads R, DeBenedetti A, Gao M, et al. Detection of eIF4E gene amplification in breast cancer by competitive PCR. Ann Surg Oncol 1997;5: 232-7.
12. Sorrells DL, Ghali G, DeBenedetti A, Nathan CO, Li BDL. Progressive amplification and overexpression of the eukaryotic initiation factor 4E gene in different zones of head and neck cancers. J Oral Maxillofac Surg 1999;57:294-9.
13. Koromilas AE, Lazaris-Karatzas A, Sonenberg N. mRNAs containting extensive secondary structure in their 5′ noncoding region translate efficiently in cells overexpressing initiation factor 4E. EMBO J 1992;11:4153-8.
14. Rosenwald IB, Lazaris-Karatzas A, Sonenberg N, Schmidt EV. Elevated levels of cyclin D1 in response to increased expression of eukaryotic initiation factor 4E. Mol Cell Biol 1993;13:7358-65.
15. Schantz LM, Coleman CS, Pegg AE. Overexpression of ornithine decarboxylase caused relief of translational repression is associated with neoplastic transformation. Cancer Res 1994;54:2313-6.
16. Kevil CG, DeBenedetti A, Payne DK, Coe LL, Laroux FS, Alexander JS. Translational regulation of vascular permeability factor by eukaryotic initiation factor 4E: implications for tumor angiogenesis. Int J Cancer 1996;65:785-90.
17. DeBenedetti A, Joshi-Bare S, Rhoads R. Expression of antisense RNA against initiation factor eIF4E mRNA in HeLA cells results in lengthened cell division times, diminished translation rates, and reduced levels of both eIF4E and p220 component of eIF4F. Mol Cell Biol 1991;11:5435-45.
18. DeBenedetti A, Joshi-Bare S, Graff JR, Zimmer SG. CHO cells transformed by the translation factor eIF4E display increased c-myc expression, but require overexpression of max for tumorigenicity. Mol Cell Diff 1994;2:347-71.
19. Rinker-Schaeffer CW, Graff JR, DeBenedetti A. Decreasing the level of translation initiation factor 4E with antisense RNA causes reversal of ras-mediated transformation and tumorigenesis of cloned rat embryo fibroblasts. Int J Cancer 1993;55:841-7.
20. Anthony B, Carter P, DeBenedetti A. Overexpression of the protooncogene/translation factoreIF4E in breast carcinoma cell lines. Int J Cancer 1996;65:1-6.
21. DeFatta R, Turbat-Herrera E, Li BDL, Anderson W, DeBenedetti A. Elevated expression eIF4E in confined early breast cancer lesions: possible role of hypoxia. Int J Cancer 1999;80:516-22.